-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
SARS-CoV-2 is the coronavirus that causes COVID-19
Researchers have found that infection of SARS-CoV-2 cells causes an increase in the level of a protein called CD47 on the cell surface
CD47 is a so-called "don't eat me" signal, which is sent to the defense system of the immune system to protect cells from destruction
It is well known that risk factors for severe COVID-19 such as old age and diabetes are associated with higher CD47 levels
These data indicate that high CD47 levels induced by aging and viruses prevent an effective immune response and increase disease-related tissue and organ damage, leading to severe COVID-19
As therapies for CD47 are under development, this discovery may lead to improved COVID-19 therapies
Professor Martin Michaelis from the University of Kent said: “This is so exciting
Professor Jindrich Cinatl of the Goethe University in Frankfurt said: "These additional insights into the disease process behind COVID-19 may help us design better therapies and recognize the importance of the breadth of ongoing research
Katie-May McLaughlin, Denisa Bojkova, Joshua D.